The faltering perf o rma n c e o f Neimeth International Pharmaceutical Nigeria Plc further accentuate the challenges facing drug makers as infrastructure deficits, high interest rate environment, government policies and macro conditions continues to crimp growth potentials.
For the year ended 30 Se
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
